UROMEMS

Science behind it. Life ahead of it.

Grenoble, France · Founded 2011 · $134.3M raised

Headquarters
Grenoble
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$134.3M
Last Round
$60.0M Corporate RoundMar 2025
Rounds
4

About

UroMems is a global medtech company co-founded in 2011 by Professor Pierre Mozer, Hamid Lamraoui, and Stéphane Lavallée, developing UroActive — the first smart, automated artificial urinary sphincter (AUS) implant for the treatment of stress urinary incontinence in both women and men. The active implantable device leverages embedded systems and micro-technologies to remotely adjust to each patient's individual needs, improving quality of life without manual patient intervention. UroMems has completed first-in-human feasibility studies in both female and male patients and received FDA IDE approval in 2025 to advance pivotal clinical trials.

Summary

UROMEMS is a Biotech company based in Grenoble, France, founded in 2011. It has raised $134.3M in total across 4 rounds, most recently a $60.0M Corporate Round round in Mar 2025. Investors include Ajax Health, Crédit Mutuel Innovation and European Innovation Council Fund.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundMar 2025
$60.0M

Sign up to see all 4 rounds

Series B through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

UROMEMS on Indexed.vc
<a href="https://indexed.vc/companies/uromems"><img src="https://indexed.vc/api/badge/company/uromems" alt="UROMEMS on Indexed.vc" width="260" height="76" /></a>